Inversions like these are some of the clearest examples of base erosion and are largely motivated by tax considerations.
I just hope that we can figure out a way, on a bipartisan basis, to fix this.
if you shudder, colleagues, at these tax-avoidance schemes; if you really get angry about matters like the double Irish ...
This is one of the most exciting parts of our economy. This is somewhere we can lead the world.
how much privacy are we going to give up in the name of security?
While these arrangements are not always problematic, we are seeing more and more of these physician-salespeople using th...
Today, we are here to explore the various issues surrounding the growth and prevalence of Physician-Owned Distributors, ...
the fraud and abuse risks, as well as (and more importantly) the patient safety concerns related to PODs, are equally ap...
Senator Hatch and I will be referring information about this allegation and about possible Sunshine Act violations to th...
If we don't allow enough data exclusivity time, we're not going to develop these therapies, especially in bio, because b...
I'm very concerned about data exclusivity.
One issue that significantly affects many entities in my home State is the FDA's October 2014 proposed guidance on the r...
The average cost, according to what I've been told, for a pharmaceutical drug is about a billion dollars...
The patient has a right to know, and then, of course, taxpayers, because you have public payers, the people of this coun...
We believe these findings will say quite a bit about the lack of accountability for these types of business relationship...
I hope that today's hearing will be another important step in our ongoing efforts to provide appropriate oversight and e...
There is really an urgent need for more transparency.
the proliferation of PODs and the lack of guidance as to how these arrangements square with existing Federal law.
